vijayalakshmi periysamy

Dr. vijayalakshmi periysamy


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2022 in Antioxidants
Verified
Journal Article
Open access
PDF file
JRJeane Rebecca Roy
Jeane Rebecca Roy
CJCoimbatore Sadagopan Janaki
Coimbatore Sadagopan Janaki
SJSelvaraj Jayaraman
Selvaraj Jayaraman
VPvijayalakshmi periysamy
vijayalakshmi periysamy
TBThotakura Balaji
Thotakura Balaji
VVVishnu Priya Veeraraghavan
Vishnu Priya Veeraraghavan
In the management of type 2 diabetes, oral antidiabetic drugs have several side effects, which in turn have led the pharmaceutical industry to search for good therapeutic, non-toxic and reliable drugs. Carica papaya (C. papaya) is one of several plants in nature that have been found to possess anti-diabetic properties. Despite studies being focused on the antidiabetic activity of C. papaya, the molecular mechanism against high fat diet induced insulin resistance is yet to be identified. The role of C. papaya was evaluated on insulin signaling molecules, such as the insulin receptor (IR) and glucose transporter-4 (GLUT4) in high fat, diet-streptozotocin induced type 2 diabetic rats, and analyzed the bioactive compounds of C. papaya against IR and GLUT4 via molecular docking and dynamics. The ethanolic extract of C. papaya leaves (600 mg/kg of body weight) was given daily to male wistar rats for 45 days and we observed the various biochemical parameters, gene expression analysis and histopathology of skeletal muscle. Molecular docking and dynamics were undertaken to understand the bioactive compounds with the greatest hit rate. C. papaya treatment was able to control blood glucose levels, the lipid profile and serum insulin, but it facilitated tissue antioxidant enzymes and IR and GLUT4 levels. The in-silico study showed that kaempferol, quercitin and transferulic acid were the top three ligands with the greatest hit rate against the protein targets. Our preliminary findings, for the first time, showed that C. papaya reinstates the glycemic effect in the diabetic skeletal muscle by accelerating the expression of IR and GLUT4.

1 January 2024 in Advances in Public Health
Verified
Journal Article
Open access
Vidhya Rekha UmapathyVidhya Rekha Umapathy
Vidhya Rekha Umapathy
PMPrabhu ManickamNatarajan
Prabhu ManickamNatarajan
BSBhuminathan Swamikannu
Bhuminathan Swamikannu
SJSabarinathan Jaganathan
Sabarinathan Jaganathan
SRSuba Rajinikanth
Suba Rajinikanth
VPvijayalakshmi periysamy
vijayalakshmi periysamy
Oral malignancy, notably oral squamous cell carcinoma (OSCC), stands as a formidable global health issue, characterized by disparate prevalence among demographics and geographic regions. Traditional diagnostic modalities, reliant on biopsy and histopathological methods, they all often exhibit constraints in expeditiousness and subjectivity, thus an alternative methodologies are needed for fostering early detection and personalized therapeutic strategies. Artificial intelligence (AI) emerges as a forefront avenue in oral cancer (OC) therapeutics, engaged in providing solutions for diagnostic augmentation, treatment optimization, and prognostic delineation. Machine learning paradigms, encompassing supervised and unsupervised learning, afford meticulous classification and pattern identification from multifarious clinical and histopathological datasets. Deep learning architectures, exemplified by convolutional neural networks (CNNs), automatize lesion detection, and characterization from medical imagery, thereby expediting diagnostic efficacy. Predictive analytics methodologies combine multifaceted patient data to access risk and prognosticate disease trajectory, thereby facilitating bespoke treatment schema. Expert systems harness medical knowledge and patient‐centric intelligence to furnish decision support for clinicians in treatment modality selection and disease monitoring. Robotic and automated systems contribute to surgical precision and procedural streamlining, ultimately fostering enhanced patient outcomes. Despite these advancements, challenges remain persists necessitating continued interdisciplinary collaboration and research efforts. This review explores about burgeoning role of AI in OC therapeutics, elucidating extant applications, challenges, and future trajectories for research and clinical adoption in oral oncology.

3 May 2024 in Toxicon
Verified
Journal Article
Closed access
USUthra Selvaraj
Uthra Selvaraj
SGSivaranjani Ganapathy
Sivaranjani Ganapathy
AMARUMUGAM MUTHUVEL
ARUMUGAM MUTHUVEL
AAAsha Monica Alex
Asha Monica Alex
JKJaved Masood Khan
Javed Masood Khan
VPvijayalakshmi periysamy
vijayalakshmi periysamy

28 January 2026 in Journal of Medico Informatics
Verified
Journal Article
Open access
YTYusuf Haroon Wafa Thabassum
Yusuf Haroon Wafa Thabassum
ZSZakir Hussain Aysha Saliha
Zakir Hussain Aysha Saliha
VVVignaraja Varsha Veronica
Vignaraja Varsha Veronica
FDFrancis Maria Dharshini
Francis Maria Dharshini
SSSahaya Josephraj Reina Sharon
Sahaya Josephraj Reina Sharon
VPvijayalakshmi periysamy
vijayalakshmi periysamy
The fast-paced development of digital health informatics is transforming the way we think about proactive, personalized and data-driven healthcare. This review underscores the integrating power of AI, wearable sensors and telemedicine platforms in facilitating real-time monitoring, early diagnosis and remote care—especially to underserved communities. It looks at how AI is driving predictive analytics, wearables are upping the ante in continuous biometric feedback, telemedicine is bridging care continuity for those who live in remote areas. The combined use of these technologies has the potential to democratize medical care and improve clinical results. Challenges yet to be addressed are data interoperability, user privacy, digital literacy discrepancies and algorithmic bias. The article also discusses new frontiers including digital therapeutics, federated learning and decentralised data ecosystems that promise to reshape patient-centred health systems even more

28 January 2026 in Journal of Medico Informatics
Verified
Journal Article
Open access
BRBaskar Ramya
Baskar Ramya
DSDeepalatha Shanmugam
Deepalatha Shanmugam
MTMuruganantham Thanushree
Muruganantham Thanushree
SHSagayaraj Hepshibaa
Sagayaraj Hepshibaa
AKArockia Raj Yasmin Kiruba
Arockia Raj Yasmin Kiruba
VPvijayalakshmi periysamy
vijayalakshmi periysamy
Around the world, most of the medical systems usually employ medicinal herbs to treat both acute and chronic wounds. The current study aims to evaluate the antibacterial properties of Moringa oleifera, Solanum nigrum, and Sesbania grandiflora. These plants were tested for antibacterial activity against wound infections by collecting and extracting the plant’s crude material. By using the Hanging drop method and the agar-well diffusion method, three distinct bacterial colonies were identified. Ethanol extract showed the most significant antibacterial activity, attributed to the presence of alkaloids, tannins, saponins, phenols, and steroids. The antibacterial activity varied for different test samples of 500 µg/ml, with the positive control serving as a reference of the expected effect. Solanum nigrum's potent antibacterial properties suggest its potential as a valuable natural resource in combating bacterial diseases, potentially aiding in future herbal medicine and pharmaceutical research. The results suggest these plants could be valuable natural resources for combating bacterial diseases.